Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DRIONASDAQ:MDAINASDAQ:POAINASDAQ:POCI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDRIODarioHealth$0.69-0.7%$0.71$0.50▼$1.55$30.68M1.58283,664 shs49,612 shsMDAISpectral AI$2.05-6.4%$1.54$0.82▼$3.25$55.44M0.7858,415 shs387,038 shsPOAIPredictive Oncology$0.86-1.7%$0.99$0.55▼$3.06$7.77M1.21.92 million shs88,606 shsPOCIPrecision Optics$4.64+6.4%$4.43$3.47▼$6.59$33.42M0.2115,423 shs17,473 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDRIODarioHealth-0.70%-1.61%-4.83%+3.24%-43.37%MDAISpectral AI-6.39%-0.49%+40.41%+45.39%+28.93%POAIPredictive Oncology-1.66%-10.83%-12.35%-49.37%-4.30%POCIPrecision Optics+6.42%+1.31%+4.88%+5.22%-21.36%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDRIODarioHealth1.195 of 5 stars3.30.00.00.00.00.81.3MDAISpectral AI3.626 of 5 stars3.75.00.00.03.23.30.0POAIPredictive Oncology1.5016 of 5 stars3.03.00.00.00.00.00.6POCIPrecision OpticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDRIODarioHealth 2.67Moderate Buy$2.00191.89% UpsideMDAISpectral AI 3.33Buy$4.75131.71% UpsidePOAIPredictive Oncology 2.00Hold$3.00250.63% UpsidePOCIPrecision Optics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest POAI, POCI, DRIO, and MDAI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2025DRIODarioHealthLitchfield Hills ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$3.004/2/2025MDAISpectral AIHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.50 ➝ $3.50(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDRIODarioHealth$27.04M1.13N/AN/A$2.11 per share0.32MDAISpectral AI$29.58M1.75N/AN/A($0.32) per share-6.41POAIPredictive Oncology$1.62M4.72N/AN/A($0.03) per share-28.52POCIPrecision Optics$19.10M1.86N/AN/A$1.66 per share2.80Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDRIODarioHealth-$42.75M-$0.56N/AN/AN/A-159.80%-65.81%-38.41%8/6/2025 (Estimated)MDAISpectral AI-$15.31M-$0.54N/AN/AN/A-30.75%N/A-11.37%N/APOAIPredictive Oncology-$12.66M-$3.05N/AN/AN/A-629.68%-671.29%-132.49%8/12/2025 (Estimated)POCIPrecision Optics-$2.95M-$0.89N/A∞N/A-32.84%-54.03%-32.48%N/ALatest POAI, POCI, DRIO, and MDAI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q3 2025POCIPrecision OpticsN/A-$0.30N/A-$0.30N/A$4.19 million5/14/2025Q1 2025DRIODarioHealth-$0.07-$0.14-$0.07-$0.14$7.48 million$6.75 million5/14/2025Q1 2025POAIPredictive Oncology-$0.09-$0.32-$0.23-$0.34$1.50 million$0.11 million3/27/2025Q4 2024MDAISpectral AI-$0.13-$0.06+$0.07-$0.41$6.83 million$7.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDRIODarioHealthN/AN/AN/AN/AN/AMDAISpectral AIN/AN/AN/AN/AN/APOAIPredictive OncologyN/AN/AN/AN/AN/APOCIPrecision OpticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDRIODarioHealth0.262.011.77MDAISpectral AIN/A1.411.37POAIPredictive OncologyN/A0.760.75POCIPrecision Optics0.111.991.26Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDRIODarioHealth33.39%MDAISpectral AI67.08%POAIPredictive Oncology9.04%POCIPrecision Optics13.71%Insider OwnershipCompanyInsider OwnershipDRIODarioHealth11.20%MDAISpectral AI30.70%POAIPredictive Oncology3.44%POCIPrecision Optics16.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDRIODarioHealth20044.46 million39.48 millionOptionableMDAISpectral AI8325.32 million17.55 millionNot OptionablePOAIPredictive Oncology308.93 million8.63 millionNot OptionablePOCIPrecision Optics807.67 million6.42 millionNot OptionablePOAI, POCI, DRIO, and MDAI HeadlinesRecent News About These CompaniesLaCroix Precision Optics Expands in Batesville, Arkansas, Creating 107 New JobsJune 5, 2025 | globenewswire.comPrecision Optics Expands Facilities to Meet Growing BacklogJune 5, 2025 | globenewswire.comPrecision Optics to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025May 27, 2025 | globenewswire.comPrecision Optics reports annual meeting resultsMay 25, 2025 | investing.comPrecision Optics Corporation: Precision Optics Reports Third Quarter Fiscal Year 2025 Financial ResultsMay 16, 2025 | finanznachrichten.dePrecision Optics Corporation, Inc. (POCI) Q1 2025 Earnings Conference Call TranscriptMay 15, 2025 | seekingalpha.comPrecision Optics Reports Third Quarter Fiscal Year 2025 Financial ResultsMay 15, 2025 | globenewswire.comPrecision Optics Market Global Forecast Report to 2030: Cumulative Impact of United States TariffsMay 14, 2025 | globenewswire.comPrecision Optics Schedules Third Quarter of Fiscal Year 2025 Conference Call for May 15, 2025May 8, 2025 | globenewswire.comPrecision Optics to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025April 21, 2025 | globenewswire.comPrecision Optics Signs Major Aerospace Deal, Expands Backlog To $6.6M With New OrdersApril 5, 2025 | nasdaq.comPrecision Optics enters into main purchase agreement with aerospace customerApril 4, 2025 | markets.businessinsider.comPrecision Optics to Participate in the Lytham [...]March 27, 2025 | aktiencheck.dePrecision Optics to Participate in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025March 27, 2025 | globenewswire.comPrecision Optics Appoints Joseph P. Pellegrino, Jr. to Board of DirectorsMarch 20, 2025 | globenewswire.comPrecision Optics Appoints Buell Duncan to Board of Directors; Dr. Richard Miles Retires from BoardMarch 4, 2025 | globenewswire.comPrecision Optics Announces Closing of $5.1 Million Offering of Common Stock to Fund Business ExpansionFebruary 24, 2025 | globenewswire.comPrecision Optics prices 1.27M shares at $4.00 in registered direct offeringFebruary 20, 2025 | markets.businessinsider.comPrecision Optics Announces Pricing of $5.1 Million Offering of Common Stock to Fund Business ExpansionFebruary 20, 2025 | finance.yahoo.comEarnings call transcript: Precision Optics Q2 FY2025 shows revenue dropFebruary 13, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePOAI, POCI, DRIO, and MDAI Company DescriptionsDarioHealth NASDAQ:DRIO$0.69 0.00 (-0.70%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$0.68 0.00 (-0.18%) As of 06/23/2025 06:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.Spectral AI NASDAQ:MDAI$2.05 -0.14 (-6.39%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$2.11 +0.06 (+2.93%) As of 06:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.Predictive Oncology NASDAQ:POAI$0.86 -0.01 (-1.66%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$0.87 +0.02 (+2.03%) As of 04:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.Precision Optics NASDAQ:POCI$4.71 +0.35 (+8.03%) As of 06/23/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
